DrugsControl Media Services
DrugsControl.org

News Detail

US FDA approves Argenx's drug for muscle-weakening disease (22-06-2023)

Amsterdam, 20 June 2023 (Reuters) The U.S. Food and Drug Administration has app......
View Details

Source : Reuters
U.S. Food and Drug Administration Argenx SE's muscle-weakening genetic disease generalized myasthenia gravis Vyvgart Hytrulo efgartigimod Halozyme

Related News